Abbott Laboratories (ABT) Net Profit Margin: History & Chart

Abbott Laboratories(ABT)

Medical - Devices · Abbott Park, IL

$105.52-2.81 (-2.59%)

Delayed quote: Sep 8, 2026, 4:02 PM EDT

About Abbott Laboratories

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Abbott Park, IL

115,000 employees

www.abbott.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Robert Ford

View full financials

ABT Net Profit Margin Metrics

NET PROFIT MARGIN

11.65%

NET PROFIT MARGIN AVG TTM

12.59%

NET PROFIT MARGIN AVG 3Y

13.84%

NET PROFIT MARGIN AVG 5Y

14.55%

NET PROFIT MARGIN AVG 10Y

12.44%

NET PROFIT MARGIN AVG 15Y

12.45%

NET PROFIT MARGIN AVG 20Y

13.07%

CURRENT VS TTM AVG

-7.45%

CURRENT VS 3Y AVG

-15.79%

CURRENT VS 5Y AVG

-19.92%

CURRENT VS 10Y AVG

-6.36%

CURRENT VS 15Y AVG

-6.46%

CURRENT VS 20Y AVG

-10.87%

SECTOR MEDIAN · HEALTHCARE

8.98%

median of 90 covered companies

CURRENT VS SECTOR MEDIAN

+29.73%

vs the sector median at left

NAME	MARKET CAP	NET PROFIT MARGIN	TTM	3Y	5Y
Abbott Laboratories (ABT)	$182.59B	11.65%	12.59%	13.84%	14.55%
Gilead Sciences, Inc. (GILD)vs ›	$182.06B	-10.64%	15.29%	17.07%	15.27%
Novo Nordisk A/S (NVO)vs ›	$200.54B	35.33%	33.96%	33.83%	33.74%
Pfizer Inc. (PFE)vs ›	$158.39B	6.81%	12.51%	14.97%	18.18%
Amgen Inc. (AMGN)vs ›	$212.20B	22.93%	16.61%	20.49%	22.20%
Danaher Corporation (DHR)vs ›	$144.25B	15.95%	15.52%	19.51%	19.37%
Thermo Fisher Scientific Inc. (TMO)vs ›	$224.09B	15.06%	14.95%	14.84%	16.47%
Vertex Pharmaceuticals Incorporated (VRTX)vs ›	$134.24B	34.89%	13.94%	25.44%	29.40%
Bristol-Myers Squibb Company (BMY)vs ›	$132.14B	18.87%	-1.95%	6.91%	3.60%
Intuitive Surgical, Inc. (ISRG)vs ›	$123.70B	28.45%	28.09%	25.67%	26.14%

NAME

MARKET CAP

NET PROFIT MARGIN

TTM

Abbott Laboratories (ABT)

$182.59B

11.65%

12.59%

13.84%

14.55%

Gilead Sciences, Inc. (GILD)vs ›

$182.06B

-10.64%

15.29%

17.07%

15.27%

Novo Nordisk A/S (NVO)vs ›

$200.54B

35.33%

33.96%

33.83%

33.74%

Pfizer Inc. (PFE)vs ›

$158.39B

6.81%

12.51%

14.97%

18.18%

Amgen Inc. (AMGN)vs ›

$212.20B

22.93%

16.61%

20.49%

22.20%

Danaher Corporation (DHR)vs ›

$144.25B

15.95%

15.52%

19.51%

19.37%

Thermo Fisher Scientific Inc. (TMO)vs ›

$224.09B

15.06%

14.95%

14.84%

16.47%

Vertex Pharmaceuticals Incorporated (VRTX)vs ›

$134.24B

34.89%

13.94%

25.44%

29.40%

Bristol-Myers Squibb Company (BMY)vs ›

$132.14B

18.87%

-1.95%

6.91%

3.60%

Intuitive Surgical, Inc. (ISRG)vs ›

$123.70B

28.45%

28.09%

25.67%

26.14%

Net Profit Margin FAQ

What is the net profit margin for Abbott Laboratories (ABT)?

The net profit margin for ABT stock is 11.65%.

Is Abbott Laboratories's net profit margin high or low?

The net profit margin of 11.65% is 20% below its 5-year average of 14.55%, near the low end of its 5-year range (7.37%–84.10%).

What is the TTM average net profit margin for Abbott Laboratories (ABT)?

The TTM average net profit margin for ABT stock is 12.59%.

What is the 3Y average net profit margin for Abbott Laboratories (ABT)?

The 3Y average net profit margin for ABT stock is 13.84%.

What is the 5Y average net profit margin for Abbott Laboratories (ABT)?

The 5Y average net profit margin for ABT stock is 14.55%.

What is the 10Y average net profit margin for Abbott Laboratories (ABT)?

The 10Y average net profit margin for ABT stock is 12.44%.

What is the 15Y average net profit margin for Abbott Laboratories (ABT)?

The 15Y average net profit margin for ABT stock is 12.45%.

What is the 20Y average net profit margin for Abbott Laboratories (ABT)?

The 20Y average net profit margin for ABT stock is 13.07%.

DATE	NET PROFIT MARGIN
2026-06-30	7.37%
2026-03-31	9.65%
2025-12-31	15.50%
2025-09-30	14.46%
2025-06-30	15.97%
2025-03-31	12.79%
2024-12-31	84.10%
2024-09-30	15.48%
2024-06-30	12.55%
2024-03-31	12.29%
2023-12-31	15.56%
2023-09-30	14.16%
2023-06-30	13.78%
2023-03-31	13.52%
2022-12-31	10.24%
2022-09-30	13.78%
2022-06-30	17.93%
2022-03-31	20.57%
2021-12-31	17.34%
2021-09-30	19.22%
2021-06-30	11.63%
2021-03-31	17.15%
2020-12-31	20.20%
2020-09-30	13.92%
2020-06-30	7.33%
2020-03-31	7.30%
2019-12-31	12.62%
2019-09-30	11.89%
2019-06-30	12.61%
2019-03-31	8.92%
2018-12-31	8.42%
2018-09-30	7.35%
2018-06-30	9.44%
2018-03-31	5.66%
2017-12-31	-10.91%
2017-09-30	8.83%
2017-06-30	4.26%
2017-03-31	6.61%
2016-12-31	14.96%
2016-09-30	-6.21%
2016-06-30	11.53%
2016-03-31	6.47%
2015-12-31	14.78%
2015-09-30	11.26%
2015-06-30	15.16%
2015-03-31	46.80%
2014-12-31	16.88%
2014-09-30	10.54%
2014-06-30	8.39%
2014-03-31	7.15%
2013-12-31	10.43%
2013-09-30	17.99%
2013-06-30	8.74%
2013-03-31	10.12%
2012-12-31	9.72%
2012-09-30	19.88%
2012-06-30	17.59%
2012-03-31	13.13%
2011-12-31	15.60%
2011-09-30	3.09%
2011-06-30	20.20%
2011-03-31	9.55%
2010-12-31	14.45%
2010-09-30	10.27%
2010-06-30	14.63%
2010-03-31	13.03%
2009-12-31	17.51%
2009-09-30	19.07%
2009-06-30	17.19%
2009-03-31	21.41%
2008-12-31	19.32%
2008-09-30	14.47%
2008-06-30	18.08%
2008-03-31	13.86%
2007-12-31	16.66%
2007-09-30	11.24%
2007-06-30	15.52%
2007-03-31	13.19%
2006-12-31	-7.66%
2006-09-30	12.84%
2006-06-30	11.13%
2006-03-31	16.69%
2005-12-31	16.15%
2005-09-30	12.64%
2005-06-30	15.88%
2005-03-31	15.57%
2004-12-31	17.24%
2004-09-30	17.18%
2004-06-30	13.49%
2004-03-31	15.78%
2003-12-31	17.08%
2003-09-30	15.71%
2003-06-30	5.22%
2003-03-31	17.49%
2002-12-31	12.96%
2002-09-30	16.59%

DATE

NET PROFIT MARGIN

2026-06-30

7.37%

2026-03-31

9.65%

2025-12-31

15.50%

2025-09-30

14.46%

2025-06-30

15.97%

2025-03-31

12.79%

2024-12-31

84.10%

2024-09-30

15.48%

2024-06-30

12.55%

2024-03-31

12.29%

2023-12-31

15.56%

2023-09-30

14.16%

2023-06-30

13.78%

2023-03-31

13.52%

2022-12-31

10.24%

2022-09-30

13.78%

2022-06-30

17.93%

2022-03-31

20.57%

2021-12-31

17.34%

2021-09-30

19.22%

2021-06-30

11.63%

2021-03-31

17.15%

2020-12-31

20.20%

2020-09-30

13.92%

2020-06-30

7.33%

2020-03-31

7.30%

2019-12-31

12.62%

2019-09-30

11.89%

2019-06-30

12.61%

2019-03-31

8.92%

2018-12-31

8.42%

2018-09-30

7.35%

2018-06-30

9.44%

2018-03-31

5.66%

2017-12-31

-10.91%

2017-09-30

8.83%

2017-06-30

4.26%

2017-03-31

6.61%

2016-12-31

14.96%

2016-09-30

-6.21%

2016-06-30

11.53%

2016-03-31

6.47%

2015-12-31

14.78%

2015-09-30

11.26%

2015-06-30

15.16%

2015-03-31

46.80%

2014-12-31

16.88%

2014-09-30

10.54%

2014-06-30

8.39%

2014-03-31

7.15%

2013-12-31

10.43%

2013-09-30

17.99%

2013-06-30

8.74%

2013-03-31

10.12%

2012-12-31

9.72%

2012-09-30

19.88%

2012-06-30

17.59%

2012-03-31

13.13%

2011-12-31

15.60%

2011-09-30

3.09%

2011-06-30

20.20%

2011-03-31

9.55%

2010-12-31

14.45%

2010-09-30

10.27%

2010-06-30

14.63%

2010-03-31

13.03%

2009-12-31

17.51%

2009-09-30

19.07%

2009-06-30

17.19%

2009-03-31

21.41%

2008-12-31

19.32%

2008-09-30

14.47%

2008-06-30

18.08%

2008-03-31

13.86%

2007-12-31

16.66%

2007-09-30

11.24%

2007-06-30

15.52%

2007-03-31

13.19%

2006-12-31

-7.66%

2006-09-30

12.84%

2006-06-30

11.13%

2006-03-31

16.69%

2005-12-31

16.15%

2005-09-30

12.64%

2005-06-30

15.88%

2005-03-31

15.57%

2004-12-31

17.24%

2004-09-30

17.18%

2004-06-30

13.49%

2004-03-31

15.78%

2003-12-31

17.08%

2003-09-30

15.71%

2003-06-30

5.22%

2003-03-31

17.49%

2002-12-31

12.96%

2002-09-30

16.59%

Net Profit Margin: 11.65%

ABT Profit Margin

ABT Average Net Profit Margin Chart

ABT Current vs Average Net Profit Margin Chart

ABT Net Profit Margin Metrics

ABT Competitors' Net Profit Margin

Margin Comparison

Net Profit Margin Formula & Definition

Net Profit Margin FAQ

ABT Net Profit Margin History

Related Metrics